Highlighted transactions

Healthcare

 

Surgical Specialties Corporation

Piper Jaffray served as exclusive financial advisor to Surgical Specialties Corporation on its sale to Vivo Capital.

Client Description

Surgical Specialties Corporation, a subsidiary of Angiotech Pharmaceuticals, has developed and manufactured branded, private label and OEM high-precision surgical instruments for over 40 years. The company offers one of the most comprehensive portfolios of blades and sutures available, including innovative products such as the Quill™ knotless tissue-closure device. The company is headquartered in Braintree, Massachusetts, with additional manufacturing facilities in Mexico, Puerto Rico, the U.K. and Germany.

Counterparty Description

Founded in 1996, Vivo Capital, LLC is a healthcare investment firm focused on investing in and building high-quality companies in the U.S. and China. With more than $1.8 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai and Beijing, China.

Back